Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month ...

The neurorehabilitation devices market is expected to grow from US$ 2.73 billion in 2023, with CAGR of 12.7% during 2023–2031 ...

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the spread of brain proteins believed to be responsible for Parkinson's ...

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...

Researchers at the Indian Institute of Technology (IIT) Madras and Christian Medical College (CMC) Vellore have developed a cost-effective, plug-and-play robot designed to provide rehabilitation ...

The Indian Institute of Technology Madras and Christian Medical College Vellore have launched PLUTO, an innovative and cost-effective robot for rehabilitation therapy. The device promises advanced ...

The Master of Science in Counseling, Option in Rehabilitation Counseling program at Cal State LA, prepares aspiring rehabilitation counselors for careers that assist people with disabilities to live ...

However, in a previous trial, spinal fusion surgery was not better than disk replacement or nonsurgical rehabilitation (JW Gen Med Jul 15 2005, p. 115, and BMJ 2005; 330:1233); whether disk ...